Jpmorgan Chase & Co »

Cg Oncology shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cg Oncology shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $419k 9.5k 43.90

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Cg Oncology

BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Franklin Resources
Cormorant Asset Management
Frazier Life Sciences Management
Holocene Advisors
T. Rowe Price Investment Management
Foresite Capital Management V

View all funds holding Cg Oncology